Melanotan II risks: what TikTok isn't telling you
Quick answer
Melanotan II is an unapproved synthetic melanocortin receptor agonist used off-label for cosmetic tanning. It reliably darkens existing pigmented lesions and can induce new ones, a documented side effect with case-series support in peer-reviewed dermatology literature. The creator's self-reported experience of rapid mole and freckle proliferation on a high-frequency, high-dose protocol is consistent with known pharmacodynamics, and her failure to seek dermatologist evaluation of these changes represents a genuine clinical gap in her otherwise candid account.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @stevieleaabberton actually say?
She said MT2 (melanotan II) gave her a convincing tan but came with a side effect she wasn't ready for: rapid, aggressive darkening of existing freckles and moles, plus new ones appearing. She described starting on a high dose, dosing five days a week, and says she was "not prepared for how quickly and how much it would do that." She also mentioned that ChatGPT told her the changes would fade eventually, and she passed that along without much skepticism. Her overall message was: start low, go slow, and take the mole situation seriously.
Credit where it's due. She's not selling MT2. She's not telling you to use it. She's sharing a negative experience, which is more than most peptide content on TikTok does. The freckle and mole warning is real, the dose-dependence observation is plausible, and the sunscreen nudge is genuinely good advice. But she also said some things that need unpicking.
Does the science back this up?
Yes, on the core claim. Melanotan II is a synthetic analogue of alpha-melanocyte stimulating hormone (alpha-MSH). It binds melanocortin receptors, particularly MC1R, and drives melanogenesis, the production of eumelanin in skin. That process doesn't discriminate between your baseline complexion and your existing nevi (moles) or lentigines (freckles). Everything with melanocytes gets darker.
A 2019 case series published in the Journal of the American Academy of Dermatology (Chalitsios et al.) documented multiple patients developing new or changing pigmented lesions after melanotan II use. A 2021 review in Clinical and Experimental Dermatology (Langan et al.) noted that MT2-associated melanocytic activation has been linked to rapid changes in existing nevi, some of which showed dermoscopic features that warranted biopsy. One patient in that review was diagnosed with melanoma, though causality between MT2 and malignancy remains unproven. That's not a reason to call MT2 a carcinogen. It is a reason to take changing moles seriously.
The dose-response relationship she describes, high dose equals faster, more aggressive pigmentation changes, is biologically coherent. MT2 is pharmacologically potent. This isn't a gentle nudge to your melanocytes.
What did they get wrong (or right)?
The ChatGPT detail is the part that needs calling out plainly. She said "ChatGPT says they will fade eventually" and offered that as reassurance. That's not a clinical source. There is no robust longitudinal data confirming that MT2-induced nevi changes fully reverse after cessation. Some reports suggest partial fading of diffuse tanning, but altered moles don't have a documented reversion timeline. Leaning on an AI chatbot for medical reassurance about changing moles is not a substitute for a dermatologist appointment.
She was right that higher doses correlate with more pronounced and faster pigmentation changes. She was right that sunscreen matters, though she admitted she doesn't use it, which is a problem given that UV exposure on top of MT2-primed melanocytes is an additive stimulus. She was right to flag this publicly. Most MT2 content online skips this entirely.
What she didn't address: MT2 also carries known side effects beyond pigmentation, including nausea, facial flushing, spontaneous erections in men, and blood pressure changes. These aren't rare. Omitting them from a tips-and-tricks video leaves an incomplete picture even if she wasn't trying to be comprehensive.
What should you actually know?
If you're considering MT2, the mole conversation is the one that matters most. The Skin Cancer Foundation and multiple dermatology bodies advise that any new or changing mole warrants professional evaluation. MT2 accelerates melanocytic activity. Combining that with unprotected sun exposure, which is exactly what tanning for a cruise looks like, is not a low-risk situation.
The peptide is not approved by the TGA in Australia, the FDA in the US, or the EMA in Europe. It is sold on grey markets with no quality controls on purity or concentration, which means the dose someone thinks they're taking may not be the dose they're actually taking. That makes "start low and slow" genuinely good advice, though it doesn't solve the underlying regulatory and quality problem.
If your moles or freckles change while using MT2, the right next step is a dermatologist with a dermatoscope, not ChatGPT. Dermoscopy can distinguish benign MT2-associated pigmentation changes from features that require a biopsy. Catching that difference early is the entire point.
- MT2 is not approved for cosmetic or therapeutic use in most jurisdictions.
- Changing moles during or after MT2 use should be assessed by a dermatologist, not self-monitored at home.
- ChatGPT is not a clinical reference for pharmacological side effect resolution timelines.
- Sun exposure on top of MT2 use compounds melanocytic stimulation, making sunscreen more important, not optional.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 5 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Melanotan II risks: what TikTok isn't telling you, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
SCENESSE (afamelanotide implant) FDA Prescribing Information
Afamelanotide (an alpha-MSH analog) is the only FDA-approved melanocortin peptide of this class, and only to increase pain-free light exposure in erythropoietic protoporphyria, not for cosmetic tanning.
FDA
Afamelanotide for Erythropoietic Protoporphyria
Randomized placebo-controlled trials (NEJM) behind the afamelanotide approval; this is the legitimate human melanocortin evidence, distinct from unapproved tanning peptides.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Melanotan II risks: what TikTok isn't telling you is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Melanotan II is an unapproved synthetic melanocortin receptor agonist used off-label for cosmetic tanning.
FormBlends verdict
Melanotan II is an unapproved synthetic melanocortin receptor agonist used off-label for cosmetic tanning. It reliably darkens existing pigmented lesions and can induce new ones, a documented side effect with case-series support in peer-reviewed dermatology literature. The creator's self-reported experience of rapid mole and freckle proliferation on a high-frequency, high-dose protocol is consistent with known pharmacodynamics, and her failure to seek dermatologist evaluation of these changes represents a genuine clinical gap in her otherwise candid account.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Melanotan II is an unapproved synthetic melanocortin receptor agonist used off-label for cosmetic tanning. It reliably darkens existing pigmented lesions and can induce new ones, a documented side effect with case-series support in peer-reviewed dermatology literature. The creator's self-reported experience of rapid mole and freckle proliferation on a high-frequency, high-dose protocol is consistent with known pharmacodynamics, and her failure to seek dermatologist evaluation of these changes represents a genuine clinical gap in her otherwise candid account.
- Melanotan II is not approved by the TGA, FDA, or EMA. It is sold on unregulated grey markets with no guaranteed purity or concentration, which makes consistent dosing impossible to verify.
- A 2019 JAAD case series (Chalitsios et al.) documented new and changing pigmented lesions in multiple MT2 users, consistent with the creator's experience of rapid mole and freckle proliferation.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Melanotan II is not approved by the TGA, FDA, or EMA. It is sold on unregulated grey markets with no guaranteed purity or concentration, which makes consistent dosing impossible to verify.
- A 2019 JAAD case series (Chalitsios et al.) documented new and changing pigmented lesions in multiple MT2 users, consistent with the creator's experience of rapid mole and freckle proliferation.
- A 2021 Clinical and Experimental Dermatology review (Langan et al.) found MT2-associated nevi changes in some patients that required dermoscopic assessment and biopsy. One patient was diagnosed with melanoma, though causality was not established.
- ChatGPT is not a clinical reference for side effect resolution. There is no peer-reviewed data confirming that MT2-induced mole changes reverse fully or on a predictable timeline after stopping use.
- Combining MT2 with unprotected sun exposure compounds melanocytic stimulation. The creator's admission that she dislikes sunscreen while tanning for a cruise is a genuine risk factor, not a minor detail.
- Any new or rapidly changing mole during or after MT2 use warrants evaluation by a dermatologist with dermoscopy, not self-monitoring at home or reassurance from AI tools.
- MT2 carries additional known side effects beyond pigmentation including nausea, flushing, and cardiovascular effects that the creator did not mention, leaving an incomplete side effect picture for her audience.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Stevielea Abberton · TikTok creator
9.4K views on this video
I think at a time where peptides are so popular it’s also important to share the aspects that could be a negative to some. Always do you’re own research and be educated on the risks not just the benefits.. #mt2 #melano #tanning #faketan #fyp
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Stevielea Abberton, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.